143 related articles for article (PubMed ID: 31969086)
1. Formulations Based on Natural Ingredients for the Treatment of Nail Diseases.
Tampucci S; Terreni E; Zucchetti E; Burgalassi S; Chetoni P; Monti D
Curr Pharm Des; 2020; 26(5):556-565. PubMed ID: 31969086
[TBL] [Abstract][Full Text] [Related]
2. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
3. Ungual and transungual drug delivery.
Shivakumar HN; Juluri A; Desai BG; Murthy SN
Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
[TBL] [Abstract][Full Text] [Related]
4. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
Bhatt V; Pillai R
J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
[TBL] [Abstract][Full Text] [Related]
5. Transungual delivery: deliberations and creeds.
Thatai P; Sapra B
Int J Cosmet Sci; 2014 Oct; 36(5):398-411. PubMed ID: 24888698
[TBL] [Abstract][Full Text] [Related]
6. Insights into drug delivery across the nail plate barrier.
Saner MV; Kulkarni AD; Pardeshi CV
J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
[TBL] [Abstract][Full Text] [Related]
7. Enhancing the nail permeability of topically applied drugs.
Murdan S
Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
[TBL] [Abstract][Full Text] [Related]
8. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
Kircik LH
J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
[TBL] [Abstract][Full Text] [Related]
9. Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.
Kreutz T; de Matos SP; Koester LS
Recent Pat Drug Deliv Formul; 2019; 13(3):203-218. PubMed ID: 31663846
[TBL] [Abstract][Full Text] [Related]
10. Management of nail psoriasis by topical drug delivery: a pharmaceutical perspective.
Thatai P; Khan AB
Int J Dermatol; 2020 Aug; 59(8):915-925. PubMed ID: 32239692
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery.
Chen K; Puri V; Michniak-Kohn B
AAPS J; 2021 Jan; 23(1):25. PubMed ID: 33439400
[TBL] [Abstract][Full Text] [Related]
12. Permeation studies of novel terbinafine formulations containing hydrophobins through human nails in vitro.
Vejnovic I; Huonder C; Betz G
Int J Pharm; 2010 Sep; 397(1-2):67-76. PubMed ID: 20620203
[TBL] [Abstract][Full Text] [Related]
13. A systematic approach to the formulation of anti-onychomycotic nail patches.
Rizi K; Mohammed IK; Xu K; Kinloch AJ; Charalambides MN; Murdan S
Eur J Pharm Biopharm; 2018 Jun; 127():355-365. PubMed ID: 29530581
[TBL] [Abstract][Full Text] [Related]
14. 1st meeting on topical drug delivery to the nail.
Murdan S
Expert Opin Drug Deliv; 2007 Jul; 4(4):453-5. PubMed ID: 17683257
[TBL] [Abstract][Full Text] [Related]
15. TranScreen-N: Method for rapid screening of trans-ungual drug delivery enhancers.
Murthy SN; Vaka SR; Sammeta SM; Nair AB
J Pharm Sci; 2009 Nov; 98(11):4264-71. PubMed ID: 19363796
[TBL] [Abstract][Full Text] [Related]
16. Transungual drug delivery: current status.
Elkeeb R; AliKhan A; Elkeeb L; Hui X; Maibach HI
Int J Pharm; 2010 Jan; 384(1-2):1-8. PubMed ID: 19819318
[TBL] [Abstract][Full Text] [Related]
17. Use of in vitro performance models in the assessment of drug delivery across the human nail for nail disorders.
Brown M; Turner R; Wevrett SR
Expert Opin Drug Deliv; 2018 Oct; 15(10):983-989. PubMed ID: 30173543
[TBL] [Abstract][Full Text] [Related]
18. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Pal P; Thakur RS; Ray S; Mazumder B
Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
[TBL] [Abstract][Full Text] [Related]
19. Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.
Chouhan P; Saini TR
Int J Pharm; 2012 Oct; 436(1-2):179-82. PubMed ID: 22705091
[TBL] [Abstract][Full Text] [Related]
20. Drug delivery to the nail following topical application.
Murdan S
Int J Pharm; 2002 Apr; 236(1-2):1-26. PubMed ID: 11891066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
